ClinicalTrials.Veeva

Menu

Resilient, Empowered, Active Living: REAL Diabetes Study

University of Southern California logo

University of Southern California

Status

Completed

Conditions

Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2

Treatments

Behavioral: Resilient, Empowered, Active Living with Diabetes
Behavioral: Information Control

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT02214641
1K01DK099202-01A1 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This three-year award will pilot-test an innovative intervention, Resilient, Empowered, Active Living with Diabetes (REAL), targeting underserved minority young adults with poorly-controlled diabetes. The individually tailored, community-based intervention merges findings of an in-depth needs assessment, principles of an evidence-based occupational therapy intervention (Lifestyle Redesign®) and evidence-based diabetes self-management strategies. A proof-of-concept study demonstrated that REAL is feasible to implement, acceptable to young adults with type 1 diabetes and type 2 diabetes, and has potential to produce positive changes in diabetes self-care and glycemic control. The study will randomize 80 young adults with diabetes to receive either the six-month REAL intervention or an attention control condition. Blinded data collectors will assess glycemic control, diabetes self-care behaviors and quality of life outcomes, as well as potential intervention mediators, before and after the six-month intervention. It is anticipated that findings from this pilot study will be used to inform a large-scale randomized controlled trial of the REAL intervention.

The study's specific aims and hypotheses are as follows:

Aim 1. Determine the intervention's efficacy for the primary outcomes: glycemic control and diabetes self-care.

Hypothesis: At 6 months (immediately following the intervention), intervention group participants will demonstrate improvements in A1C and diabetes self-care as compared to control group participants.

Aim 2. Conduct exploratory analyses of the intervention's impact on secondary outcomes and potential mediating mechanisms (to inform power estimates for a large-scale RCT).

Hypothesis 1: At 6 months, intervention group participants will demonstrate improvements in secondary outcomes: diabetes-related stress and quality of life, depression, and life satisfaction as compared to control group participants.

Hypothesis 2: At 6 months, intervention group participants will demonstrate improvements in potential mediators of the intervention: habit strength, problem solving, activity participation, self-efficacy and diabetes knowledge as compared to baseline.

Aim 3. Conduct a process evaluation utilizing mixed methods to evaluate and refine intervention delivery (e.g. treatment fidelity, patient satisfaction) and study procedures (e.g. recruitment, retention, testing protocol).

Enrollment

81 patients

Sex

All

Ages

18 to 30 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with type 1 or type 2 diabetes mellitus for a minimum of 12 months
  • Most recent A1C ≥8.0%
  • Fluent in English or Spanish
  • Reachable by telephone or text message
  • Willing to participate in study activities
  • Reside in Los Angeles County with no plans to relocate

Exclusion criteria

  • Pregnant or planning to become pregnant
  • Cognitive impairment or severe disability limiting life expectancy
  • Participated in lifestyle intervention targeting diabetes within past 12 months
  • Participated in formative research related to intervention development.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

81 participants in 2 patient groups

Lifestyle intervention
Experimental group
Description:
Resilient, Empowered, Active Living (REAL) Diabetes
Treatment:
Behavioral: Resilient, Empowered, Active Living with Diabetes
Information Control
Active Comparator group
Description:
Participants will receive a packet of informational materials about diabetes, and receive periodic follow-up phone calls to match for attention dose.
Treatment:
Behavioral: Information Control

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems